An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
Recruiting · NCT05085171 · Interventional (participants receive a specific treatment) · Lead sponsor: Makerere University
View the official record on ClinicalTrials.gov →Interventions studied
Enhanced care package
What this trial is about
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age \>18 years
- CD4\<200 cells/µL
- Ability and willingness to give informed consent for the enhanced package of care arm.
Exclusion criteria
- Known virologic suppression (viral load \<1000 copies/mL) within prior 3 months
- Cannot or unlikely to attend regular clinic visits
Where it is running
1 location listed.
- kisugu health center IV - Kampala, Uganda